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ADM Archers Daniel Midland
B2B business-to-business
B2C business-to-consumer
FAO Food and Agriculture Organization of the United Nations
GM genetically modified
GMO genetically modified organism
LMICs low- and lower-middle income countries
N/A not available
RUF ready-to-use food
US United States 
USAID  US Agency for International Development
Abbreviations
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A broad term that refers to any proteins intended to replace animal-source proteins derived 
from traditional livestock. These might include proteins derived from plants, microorganisms, 





Business-to-business (B2B) describes a transaction that is conducted between two 
businesses, such as a manufacturer and a corporate retailer.1 This is in contrast to a business-




Defined by the US Department of Agriculture as “detectable genetic material that has been 
modified through in vitro recombinant deoxyribonucleic acid (rDNA) techniques and for which 
the modification could not otherwise be obtained through conventional breeding or found in 
nature; provided that such a food does not contain modified genetic material if the genetic 
material is not detectable.”3
Cellular 
agriculture
Cellular agriculture is the manufacture of animal products from cells rather than from 
traditional animal farming methods of breeding, rearing, and slaughter.4 The two main types of 
cellular agriculture are fermentation-based and tissue engineering–based processes.5
Cultured proteins Also known as “synthetic,” “lab-grown,” “fermentation-derived,” and “flora-based” proteins, 
cultured proteins are produced through fermentation wherein unicellular organisms (e.g., 
microflora such as fungi and yeast) express a desired organic molecule end product during the 
fermentation process.6 
Cell-based meat Also known as “clean,” “lab-grown,” “cultivated,” “cultured,” and “in vitro” meat, cell-based 
meat is the product of a cellular agriculture process that utilizes a cell or tissue line from a living 




Defined by the World Health Organization as “foods derived from organisms whose genetic 
material (DNA) has been modified in a way that does not occur naturally (e.g., through the 




Defined by the World Health Organization as “organisms (i.e., plants, animals or 
microorganisms) in which the genetic material (DNA) has been altered in a way that does not 
occur naturally by mating and/or natural recombination. The technology is often called ‘modern 
biotechnology’, or ‘gene technology’, sometimes also ‘recombinant DNA technology’, or ‘genetic 
engineering.’”8
Market size Market size refers to the total potential market for a product. In this analysis, this may be 
calculated in terms of number of people reached, volume of food, or value in dollars. Note that 
this is not indicative of the potential uptake or demand for this product, but instead estimates 
the total size.
Microflora A group of microorganisms, including algae, fungi, and bacteria, that live in a particular habitat 
(e.g., intestines).9
1. The existing market size for milk and eggs varies 
substantially across countries by income status, and 
the rapid rise in plant-based protein alternatives in 
high-income countries suggests increased demand 
for alternative non-animal protein products. The global 
market for milk and eggs is sizable, estimated at US$874 
billion and $258 billion, respectively. Of this, consumption 
in LMICs makes up approximately 33% of the milk-based 
product market and 15% of the egg market. High-income 
countries consume roughly six times more milk products 
per capita and nine times more eggs per capita than 
low-income countries. Within the food aid market, only 
a small proportion of the current products contain milk 
protein and no food aid products contain egg protein. 
However, new data are beginning to elucidate the value of 
more diverse diets and the contribution of animal-source 
foods for early childhood growth and development. 
Consumption of milk and eggs in high-income countries 
is likely driven by a variety of factors, including 
advertising; lobbying; detailed food-based dietary 
guidelines; and government programs, including 
school milk programs. Such efforts aimed at increasing 
consumption, which are common in high-resource 
markets, are lacking in most LMICs. Furthermore, sales of 
plant-based milk and egg alternatives have grown rapidly 
in recent years in high-income countries, highlighting the 
demand for alternatives to proteins made from animals 
among select consumers.
2. Cultured proteins are expected on the market in 
high-income settings in early 2020 and contain several 
attributes that may make them suitable for use in LMICs. 
Two companies that are expecting to launch their 
products in 2020 have partnered with large, multinational 
food companies with the goal of expanding capabilities 
to scale proteins and launch in broader geographic 
markets. Business-to-business sales strategies will 
likely be common given that many manufacturers plan 
to sell cultured proteins as an ingredient rather than as 
a complete end-to-end food product. Product attributes 
that may be compelling for LMIC settings include the 
potential to store without refrigeration, possibly a longer 
shelf life, and improved distribution (lighter and more 
compact). Products will likely initially be priced similar to 
existing animal-source foods, but price reductions may 
be possible with economies of scale.
3. Most non-manufacturer stakeholders were “very 
aware” or “somewhat aware” of cultured proteins before 
being interviewed, and in aggregate had very positive 
perceptions for use in LMICs but questioned feasibility 
of product pricing. According to these stakeholders, the 
The global burden of malnutrition is unacceptably high. 
Animal-source foods are important components of diverse 
diets and provide high-quality proteins and other essential 
nutrients that promote optimal growth and development.
The global demand for animal-source foods is projected 
to increase substantially, particularly in many low- and 
lower-middle income countries (LMICs). However, cost is 
a significant barrier to access, and meeting this growing 
demand through livestock production will be highly resource 
intensive. As such, sustainable, high-quality alternatives 
to protein from livestock have the potential for significant 
transformative impact for both people and the planet.
This analysis focuses on fermentation-derived cultured 
proteins as a specific alternative to animal-source proteins, 
given their near-term time to market, product qualities, and 
potential to be used in LMIC settings. Most cultured protein 
manufacturers are currently focused on creating milk (casein 
and whey) and egg white cultured protein products. Using a 
process known as fermentation-based cellular agriculture, 
animal proteins found in milk and eggs can be produced 
without animals. Through this method, a gene encoded 
with an animal protein is introduced into a starter culture 
of microflora (e.g., fungi or yeast). This culture is grown in 
controlled fermentation tanks, where it expresses the desired 
protein. Finally, the protein is separated from the microflora, 
generally producing a purified protein powder. These 
resulting “cultured” proteins are designed to be identical to 
the corresponding animal-source proteins produced through 
traditional livestock farming and can be used as ingredients 
in existing or new food products. Although there are many 
potential sustainability and nutrition-related benefits of 
these innovations, they also face several challenges to 
commercialization and market uptake.
To assess the market for cultured proteins in LMICs, we 
collected secondary data and conducted interviews with 
25 key stakeholders between January and September 2019. 
Stakeholders included knowledge experts in the food industry, 
manufacturers of cultured proteins and other alternative 
proteins, and individuals working in food aid and nonprofit 
organizations. This paper identifies key manufacturers and 
provides insights into the attributes of their products, time to 
market, prioritized geographies, key partnerships, ability to 
scale, and opportunities and challenges for commercialization. 
Secondary data are used to assess the current market for 
alternative proteins and estimate the cultured protein market 
size for different market segments. Additionally, perceptions 
from non-manufacturer stakeholders are presented to 
understand the value of these proteins for use in LMIC settings. 
Several key findings were identified.
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Executive summary
top-valued attributes of cultured proteins for use in 
LMIC settings were equally high nutritional value, lower 
environmental footprint, and equivalent or lower cost 
than their respective animal-source proteins. However, 
some stakeholders questioned whether cultured proteins 
could be made at a lower cost than animal-source foods. 
Low cost was deemed as a key success factor for market 
uptake in LMIC settings. In addition, some stakeholders 
thought that with additional research and development, 
cultured proteins could possibly be designed to meet 
the nutritional needs of specific at-risk populations, by 
adding in vitamins, minerals, specific amino acids, or 
other components.
4. Continuing to expand on the evidence base for the use of 
cultured proteins in LMICs will be important to generate 
demand in these countries. Additional evidence should be 
collected to assess factors such as cost and nutritional 
benefits, especially for use in vulnerable, malnourished 
populations. Stakeholders agreed that having a low-cost 
product would be a significant success factor for market 
uptake in LMICs. More research is needed to understand 
what price reductions may be possible with large-scale 
production. Pricing analysis should consider potential 
cost reductions of cultured proteins over animal-source 
proteins in terms of delivery and refrigeration. 
Information was also desired on how cultured proteins 
compare to animal-source foods in terms of health 
and nutrition. Many of the stakeholders participating in 
this research noted that there may be other beneficial 
components in milk and eggs that contribute to health 
besides proteins. 
Cultured proteins hold promise for significant transformative 
impact in the areas of health, agriculture, and the environment. 
The large market size, recent demand for alternative 
plant-based proteins, promising product attributes, and 
positive perceptions for use in LMIC settings make them a 
compelling area for future investment. Additional evidence 
and demand generation activities will be needed to support 
use in vulnerable, malnourished populations. 
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Background 
Introduction
The global burden of malnutrition is unacceptably high.10 Worldwide, an estimated 
22% of children under the age of five were stunted and 8% were wasted in 2018.11 
Low-quality diets lacking in essential vitamins, minerals, proteins, and other 
nutrients are a key contributor to this burden.12 Animal-source foods—such as 
meat, poultry, fish, eggs, and dairy—are important components of a diverse diet 
and provide high-quality proteins and other essential nutrients that promote 
optimal growth and development.13,14,15,16,17 As populations and incomes grow, the 
global demand for animal-source foods is projected to increase substantially, 
particularly in many low- and lower-middle income countries (LMICs).18,19
However, cost is currently a significant barrier to animal-source food consumption. 
In addition, meeting this growing demand for animal-source foods will require rapid 
increases in livestock production, which has significant environmental impacts, 
requiring considerable land, water, chemical, and energy inputs.10,17,18 Global food 
production is responsible for roughly one-quarter of all greenhouse gas emissions, 
most of which (up to 80%) are related to livestock.20,21 Livestock production is also 
a contributor to water pollution, deforestation, land degradation, overfishing, and 
antimicrobial resistance.20,22,23 
Given these challenges, this report aims to assess the market for potentially more 
sustainable alternative proteins and their potential for use in LMIC settings. The 
report focuses on proteins derived from fermentation-based cellular agriculture, 
called cultured proteins, given their potential near-term time to market and their 
potential impact in LMIC populations. Most cultured protein manufacturers are 
developing proteins that are present in animal-source milk and eggs. 
Cellular agriculture
The term “cellular agriculture” broadly refers to the manufacture of animal products 
from cell cultures under controlled conditions, as opposed to traditional animal 
farming methods.6 According to Stephens et al. (2018), cellular agriculture can 
be broadly categorized into two main groupings: fermentation based and tissue 
engineering based.5,24 Tissue engineering–based cellular agriculture produces 
cell-based meat (also known as “clean,” “lab-grown,” “cultivated,” “cultured,” and 
“in vitro” meat) and uses a cell or tissue line from a living animal. Stem cells are 
extracted from the tissue to grow and culture the desired product.5
Fermentation-based cellular agriculture—the focus of this paper—uses microflora 
(e.g., fungi or yeast) to express a desired organic molecule end product (such as 
protein) during fermentation.6 Through this process, which bears resemblance 
to brewing beer, many of the same animal proteins found in milk and eggs can be 
produced without animals.6 The process uses a gene encoded with the animal 
protein, which is introduced into the DNA of a starter culture of microflora. This 
culture is then fed on a substrate (e.g., sugars) in controlled fermentation tanks, 
where it expresses the desired protein(s).6 In most cases, the proteins are 
separated from the microflora and purified into a powder. The resulting “cultured” 
proteins—also known as “synthetic,” “lab-grown,” “fermentation-derived,” and 
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“flora-based” proteins—are theoretically identical to the 
corresponding animal-source protein with respect to 
structural, organoleptic, and nutritional properties.a,6 
Cultured proteins could therefore be substituted for 
animal-source proteins as an ingredient in existing or new 
food products, such as milk or egg substitute products. They 
might also be used to improve the nutritional content of 
products that do not currently contain milk or egg protein. 
However, cultured milk and egg proteins produced through 
this technique are not equivalent to whole animal-source 
foods (e.g., powdered whole milk or powdered whole 
eggs) because they do not contain other nutrients such as 
carbohydrates, fats, or other bioactive compounds. Several 
emerging biotechnology companies are creating cultured milk 
and egg proteins for use in food products, with the earliest 
commercial products expected on the market in 2020.
a. For the remainder of this paper, we will refer to proteins derived according to this 
approach as cultured proteins.
Potential benefits and challenges 
Benefits
Cultured milk and egg protein production techniques 
and resulting products have the potential to benefit 
the environment, agriculture, and health, including for 
malnourished populations in LMICs. Relative to the same 
proteins from animal sources, it is possible that cultured 
proteins will contain the same high nutritional value; have a 
lower environmental footprint and produce fewer associated 
greenhouse gas emissions; require fewer agricultural 
inputs (e.g., land, water, chemicals, energy); require no 
animal breeding or slaughter; contain fewer or no hormones, 
antibiotics, or foodborne pathogens; have an extended 
shelf life (may not require cold storage); have the same taste, 
texture, and chemical structure; and eventually be lower cost 
and/or be subject to fewer price fluctuations. Due to these 
potential benefits and our growing understanding of the role 
of animal-source foods in promoting nutrition, particularly 
among young children,13,14,15,16,17 cultured milk and egg proteins 
may have a role in sustainably supporting improved diets 
and nutritional outcomes in LMICs.
Challenges
At the same time, cultured proteins may also face or present 
commercialization challenges. Potential challenges 
associated with cultured proteins include displacement of 
other foods in the food system, difficulty in ensuring equitable 
access to products, the potentially high cost of these 
products when they first launch, negative livelihood impacts 
for farmers, and other possible unintended consequences. 
Furthermore, the microflora (e.g., yeast) used as a 
starter culture in the production of cultured milk and egg 
proteins is often genetically modified (GM). Genetically 
modified organisms (GMOs) are defined by the World 
Health Organization as “organisms (i.e., plants, animals or 
microorganisms) in which the genetic material (DNA) has 
been altered in a way that does not occur naturally by mating 
and/or natural recombination.”7,8 Foods that are produced 
from or with GMOs are often referred to as GM foods.7 The 
technology used to alter the genetic material of an organism 
is often referred to as “genetic engineering.”8 However, in 
the case of cultured milk and egg protein production, it is 
important to note that, in most cases, the GM microflora is 
removed from the final product, meaning that the resulting 
purified protein powder does not contain GMOs. Although 
the use of genetically engineered microbial strains in food 
production is not a new phenomenon, nuances in the details 
of the role of GMOs in the production of cultured proteins, 
as well as various country/institutional classification 
guidelines for GMOs and GM products, may add a layer of 
complexity to their regulation within various contexts. These 
considerations are discussed in detail in the accompanying 
Policy and Regulatory Environment paper. 
Key objectives of this analysis
We conducted a market landscape and market analysis of 
cultured proteins based on desk research and stakeholder 
interviews. The key objectives of this analysis included:
1. Identifying key manufacturers in the cultured protein field.
2. Gaining insights on select product attributes and their 
suitability for use in LMICs.
3. Learning about time to market, geographies for 
introduction, scalability, and priority market segments.
4. Estimating the market size for select scenarios of use in 
LMICs.
5. Understanding perspectives on opportunities and 
challenges for commercialization in LMICs.
6. Articulating the value proposition of cultured proteins 
compared to animal-source proteins.
While the focus of this report is on cultured proteins, other 
alternative protein categories were investigated (plant-based 
protein products and cell-based meats) to gain additional 
insights on the alternative protein market as a whole. 
Plant-based protein products that are intended to replace 
animal-source foods (e.g., meat, milk, and eggs) are already 
on the market, seeing rapid growth in high-income countries, 
and are a useful analog to understand potential consumer 
demand for other alternative proteins. Cell-based meats 
have longer development timelines than cultured proteins but 
provide an opportunity to obtain additional perspectives from 
manufacturers on the potential opportunities and challenges 
in the alternative protein market. 
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Research methodology
Secondary research
To achieve the objectives of this project, we conducted a combination of secondary 
and primary research. Secondary data collection focused on identifying and 
gaining knowledge on cultured protein and other alternative protein manufacturers 
and their products, the market conditions and current market size for 
animal-source milk and egg proteins, and the uptake of other forms of alternative 
proteins. Approximately 40 manufacturers of cellular agriculture products 
(including cultured proteins and cell-based meats) were identified in the first 
quarter of 2019, via the Alternative Protein Show and other sources.25 We collected 
publicly available information about each manufacturer’s location, number of 
employees, types of proteins and products produced, timeline for commercial 
availability, production technology, funding sources, and other relevant details. 
Further, we researched select plant-based protein companies, and collected 
information on the existing market for animal-source milk and eggs, food aid in 
LMICs, and the evolving food industry. Secondary data sources included white 
papers, industry reports, manufacturer websites, news publications, United 
Nations agency websites (the Food and Agriculture Organization of the United 
Nations, or FAO), policy and research institutes (Good Food Institute, International 
Food Policy Research Institute, and New Harvest), and others. The secondary 
research information was used to inform stakeholder interviews and the market 
analysis. See the reference list for a full list of sources.
Stakeholder selection and interview 
methodology 
To obtain a broad set of perspectives, a variety of stakeholder types were recruited 
for the interviews (Table 1). Stakeholders were identified through previous work in 
the field, industry conferences, desk research, and referrals. Some of these groups 
are known for their work in alternative proteins, while others participate in the 
broader food industry or are experts in food aid or the regulatory environments for 
innovative foods. In addition, we sought to obtain perspectives from around the 
world, or from respondents who work or have worked in LMICs.
We interviewed representatives of companies that are developing cultured 
proteins, that are further along in the development process for cell-based meat, 
and that are already selling plant-based proteins. Most major identified cultured 
protein manufacturers were contacted with a request to interview, especially 
those focused on milk and egg proteins, while only select cell-based meat and 
plant-based companies were contacted. The five cultured protein manufacturers 
interviewed are profiled in this report.
In total, 50 people from 43 organizations were invited to participate in an interview. Of 
those, we interviewed 25 people from 24 organizations, located in ten countries. While 
56% of respondents are based in the United States, the majority of non-manufacturer 
respondents have direct experience working in LMICs. See Table 1 for a summary of 
the stakeholders interviewed and Figure 1 for a map of stakeholders’ locations.
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 Food aid organization 
(donor, supplier, procurer, or 
distributor)
6 Arla Foods Ingredients, Catholic Relief Services, 
Nutriset, US Agency for International Development, 
World Food Programme, World Vision 
Non-profit organization  
(research, advocacy, or professional 
group)
4 Cellular Agriculture Society, Good Food Institute 
(x2), New Harvest
Other 5 Academia: Stanford University
Donor/incubator: IndieBio
Government agency: Ethiopia Agriculture 
Transformation Agency
Other: Independent experts (x2)
TABLE 1.  Number of stakeholders interviewed by type.











Note: While 56% of respondents are based in the United States, the majority of non-manufacturer respondents have direct experience working in LMICs.
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In order to conduct the interviews, the team generated 
a modular, semi-structured discussion guide that 
included both qualitative and quantitative questions. All 
interviews were designed to last approximately one hour. 
The discussion guide and research approach received a 
non-research determination from PATH’s Office of Research 
Ethics, and each stakeholder consented to the interview. 
We asked manufacturers a series of questions about the 
alternative protein products they are creating, the regulatory 
processes they are navigating or anticipating, production 
and scale-up capabilities, prioritized market segments for 
introduction and scale, and industry partnerships.
We asked non-manufacturer stakeholders about a series 
of topics based on their expertise. Each participant was 
emailed a concept card describing cultured proteins 
to review before the interview (Appendix A). During the 
interview, we asked the participants questions related to 
their prior knowledge of cultured proteins, their perceptions 
on expected key benefits and potential challenges to 
market uptake, and their views on the utility of cultured 
proteins. When relevant, we asked stakeholders about 
their knowledge of the regulatory environment in various 
regions, specifically for innovative foods, GMOs, or 
cultured proteins. The policy and regulatory environment 
information is summarized in a separate report. 
Procurement organizations or organizations working in 
global food aid were asked additional questions about 
current procurement of animal-source proteins, levels of 
awareness about cultured proteins in their industry, data 
that should be generated for uptake, and thoughts on 
potential uses of these products. We compiled data from all 
interviews for analysis. 
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Current market for milk and eggs 
• Consumption of milk and eggs varies dramatically by country income, 
with high-income countries consuming roughly six times more milk 
products and nine times more eggs per capita than low-income 
countries.
• Country-level food-based dietary guidelines for dairy vary globally, 
and not all countries include dairy recommendations. Milk is included in 
guidelines more often than eggs.
• Detailed dietary guidelines, government initiatives, school programs, 
marketing campaigns, income, and lobbying efforts are factors that 
likely contribute to higher rates of dairy consumption in high-income 
countries compared to LMICs.
• Within the food aid market, milk is currently used as an ingredient in 
a small number of products (while eggs are not used), though there is 
potential to expand the use of milk in food aid products more broadly to 
increase protein content.
• In high-income countries, sales of plant-based alternatives to milk, 
eggs, and other animal-source proteins are rapidly expanding each 
year, indicating a demand for alternatives to animal-source proteins.
Key messages
Global context 
Several factors contribute to existing milk and egg consumption levels globally. 
These may include income levels, food-based dietary guidelines, marketing 
efforts, and school lunch programs and other initiatives. Variations in these 
factors across countries may help to explain why consumption rates differ so 
dramatically by country.
Food-based dietary guidelines can be used as a mechanism to translate 
evidence regarding food, dietary patterns, and health into culturally appropriate 
recommendations. These country-based guidelines are intended to inform 
consumer behavior and, in some circumstances, inform national or government 
policies. Food-based dietary guidelines are available for 90 countries globally; 
however, only 7 countries in Africa and 17 in Asia have guidelines on this topic.26 One 
recent study that reviewed the various food-based dietary guidelines found that 
some elements of dietary guidance are nearly universal across all countries, while 
others, including dairy, are not (Table 2).26
The study found that 75% of available country dietary guidelines reviewed include 
dairy, either in messaging in the guidelines or in the visual food guide (a visual 
representation of the dietary guidelines).26 Of the guidelines that include dairy, all 
messaging specifically mentions milk; 51% mentions milk products, yogurt, or 
cheese; and 11% mentions non-dairy alternatives to milk (such as soy milk). Eggs 
are less frequently mentioned in these country guidelines, and are mentioned in 
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multiple places. In all, 31% of countries have key messaging 
related to eggs within the context of other protein foods, 
while only 3% (all in Latin America) include eggs within the 
context of dairy.26
Detailed dietary guidelines are one factor that may 
contribute to the high consumption of milk in high-income 
countries like the United States. In 2013, the average person 
in the United States consumed 255 kg of milk-based 
products per year (seventeenth in the world), while the 
country as a whole consumed 80 billion kg of milk-based 
products per year (second in the world, only behind 
India).27 The US Department of Agriculture’s 2015-2020 
Dietary Guidelines for Americans includes dairy as one 
of six pillars for a healthy eating pattern.28 Their dairy 
classification includes milk, yogurt, cheese, and fortified soy 
beverages, also known as soy milk. These guidelines make 
recommendations on consumption of dairy by age, ranging 
from two cups a day for children aged two to three years to 
three cups a day for children older than nine. The guidelines 
also make consumption recommendations for “protein 
foods,” including seafood, meats, poultry, eggs, and other 
foods.28 Specific recommendations on egg consumption 
quantities, however, are not provided. 
In addition to the dietary guidelines, government initiatives 
are likely a contributor to levels of milk consumption, 
especially in high-income countries. In the United States, 
milk has been highly promoted in school lunch programs and 
other initiatives. The US government’s National School Lunch 
Program, which provides “nutritionally balanced” low-cost or 
free lunches, served more than 30.4 million children in 2016.29 
The program was signed into law by President Harry Truman 
in 1946. In order to qualify for assistance, participating 
schools must adhere to standards set by the program. These 
standards specify the inclusion of milk (one cup), as well 
as fruits, vegetables, grains, and meat/meat alternatives.30 
Eggs are not specifically called out in the standards. The 
US government also has a Special Milk Program, which can 
provide milk to children in schools and childcare institutions 
Recommendations that are nearly universal across most 
countries
Recommendations that are variable or inconsistently 
included across countries
• Consume a variety of foods.
• Consume some foods in higher proportions than others.
• Consume fruits and vegetables.
• Consume legumes.
• Consume animal-source foods.*
• Limit sugar, fat, and salt.
• Dairy consumption.
• Red meat consumption.
• Fats and oils consumption.
• Nuts consumption.
TABLE 2. Comparison of country food-based dietary guidelines.
that do not participate in other federal meal service 
programs.31 These government-led efforts are supported by 
strong lobbying by the dairy industry to promote milk as the 
best source of protein and calcium for children.32
Finally, marketing efforts are a likely contributor to high 
consumption of milk and eggs. In the United States, the iconic 
“Got Milk?” campaign, launched in 1993 by the California Milk 
Processor Board, promoted increased milk consumption 
for nearly 20 years. The campaign was widely disseminated, 
and generated more than 90% awareness.33 Similarly, the 
American Egg Board launched “The Incredible, Edible Egg” 
marketing slogan in 1976 to promote consumption of eggs.34 
In contrast to the United States, fewer efforts are focused on 
increasing milk or egg consumption in LMICs. As mentioned 
previously, few African and Asian countries have reported 
food-based dietary guidelines.35 Dairy consumption is 
strongly emphasized in North America and Europe, where 
100% and 82% of countries in each region, respectively, have 
a key message about dairy in their guidelines. In contrast, 
only 57% of countries in Africa and 53% of countries in Asia 
have a key message regarding dairy in their guidelines. 
To raise awareness of the health benefits of school milk 
programs internationally, World School Milk Day was started 
in 2000 and is now promoted annually by the FAO and 
celebrated every September in more than 25 countries.36 
However, school milk direct-to-consumer marketing efforts 
to increase awareness of the benefits of milk, like “Got Milk?,” 
are likely more limited in LMICs. 
Other key constraints in LMICs that likely impact 
consumption of milk and egg products include lack of 
access to refrigeration and low/limited income. The 
nationally representative Demographic and Health Survey 
found that on average only 36% of households in LMICs had 
refrigerators.37 In addition, milk and eggs are a relatively 
expensive source of calories in LMICs. Studies have found 
that the prices of these foods are strongly associated with 
consumption patterns.26 
*In 31% of country guidelines, dairy is included in the animal-source food group. Dairy is a distinct category in the majority (59%) of country guidelines.
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Consumer milk and egg market
According to the most recent data available, global 
consumption of milk-based products (including 
animal-based milk, milk powder, whey, casein, yogurt, 
cheese, and ice cream)b was estimated in 2013 to be 631 
billion kg per year (an unweighted average of 114 kg per capita 
per year across 173 countries included in the dataset).27 This 
was ten times larger on a volume basis than the annual egg 
consumption estimate arrived at in 2013, which was more 
than 63 billion kg per year (an unweighted average of 7 kg per 
capita per year across 173 countries included in the dataset).27 
When looking at the annual market value, both markets are 
sizeable. While the cost of milk can fluctuate substantially 
due to economic and political trends,38 the average global 
retail cost of milk was approximately US$1.38 per kgc as of 
2013-2014 (unweighted average across 151 countries).39,40 
Applying the cost of milk as a proxy to all milk-based 
products, the estimated annual global market value for 
milk-based products is almost $874 billion.d In comparison, 
eggs have a higher cost per kg than milk (approximately 
$4.08 per kg,e based on an unweighted average across 151 
countries).41,42 Therefore, the annual value of the egg market 
is estimated to be more than $258 billion, representing about 
30% of the value of the milk market. Similar to milk, the cost 
of eggs can fluctuate seasonally or annually, often due to 
naturally increased supplies in the spring and summer.43 
b. Milk consumption does not include human breast milk or infant formula. 
c. This was reported as cost per liter of milk and converted to cost per kg of milk to match 
consumption data; 1 kg of milk is equal to 1.03 L of milk.
d. The price of milk is used as a proxy for the price of milk products (e.g., milk, cheese, and 
yogurt) to estimate the market value.
e. This was reported as cost per dozen eggs and converted to cost per kg of eggs to match 
consumption data; 1 medium egg is approximately 0.05 kg.
When looking at these data across all countries, there are 
clear disparities by income (Figure 2). High-income countries 
consume, on average, 188 kg/capita/year of milk-based 
products and 11 kg/capita/year of eggs.27 This is roughly six 
times more than the average milk consumption in low-income 
countries (29 kg/capita/year) and roughly nine times more 
than the average egg consumption in low-income countries (1 
kg/capita/year). Across only LMICs, the total annual market 
size for milk-based products is approximately 211 billion kg 
(or $292 billion),39 while the annual market size for eggs is 10 
billion kg (or $41 billion).41 This represents the market size and 
value for complete milk and egg products, not just the protein 
content. When looking at the data over time, per capita 
consumption of milk-based products and eggs has seen only 
minimal growth in the past 20 years, with the most growth 
seen in low-income countries and the most year-over-year 
fluctuations seen in high-income countries.27 However, as 
populations grow, total consumption of milk-based products 
and eggs continues to rise.
Food aid market
Food aid (or in-kind food commodities) is defined as the 
provision of food commodities by one country to another to 
help a country meet its food needs.45 Several stakeholders 
mentioned the potential for cultured protein use in the food 
aid market for LMICs, particularly given that some fortified 
or specialized food products contain milk or milk powder. 
As such, an analysis was performed to estimate the annual 
market size for food aid globally. Food aid can be provided 
for emergency relief situations or to populations that are 
vulnerable to hunger or malnutrition.46 Data on both total 
FIGURE 2. Consumption of milk-based products and eggs per capita by country income group (2013).
Note: We grouped countries by income classification, according to the World Bank,44 and calculated an unweighted average kg per capita consumption of milk and eggs. 
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food aid spending and total volume of food aid delivered 
each year are limited, thus available data and assumptions 
were used to estimate the market size.
The US Agency for International Development (USAID) is the 
largest provider of food assistance in the world, through 
its Office of Food for Peace.45 In 2017, Food for Peace’s total 
global food aid contributions, including only food aid and 
excluding community development funds and economic 
support funds, was $3.538 billion, which included 3.125 
billion kg of food aid.47 Based on these data, the average 
cost per kg of food delivered by Food for Peace in 2017 was 
approximately $1.13. While Food for Peace does not represent 
the entire food aid market, which is also supplied by other 
organizations, it represents a lower bound estimate for the 
size of the food aid market (Table 3). 
Value Detail Source
$3,538,000,000 Total Food for Peace spending on food aid in 
2017 
Food for Peace 2017 annual reporti
3,124,669,000 Total volume of food aid delivered by Food for 
Peace in 2017 (kg)
Food for Peace 2017 annual reporti
10% Maximum estimated amount of milk protein 
used in food aid (% of total food volume)
Assumption based on current USAID RUF 
guidelinesii
5% Middle estimated amount of milk protein used 
in food aid (% of total food volume)
Assumption based on current USAID RUF 
guidelinesii
1% Minimum estimated amount of milk protein 
used in food aid (% of total food volume)
Assumption based on current USAID RUF 
guidelinesii
312,466,900 Maximum estimated amount of milk protein 
used in food aid (kg)
Calculation
156,233,450 Middle estimated amount of milk protein used 
in food aid (kg)
Calculation
21,246,690 Minimum estimated amount of milk protein 
used in food aid (kg)
Calculation
$6 Cost per kg of milk protein Dairy for Global Nutritioniii
$1,874,801,400 Maximum estimated value of milk protein used 
in food aid 
Calculation
$947,400,700 Middle estimated value of milk protein used in 
food aid 
Calculation
$187,480,140 Minimum estimated value of milk protein used 
in food aid 
Calculation
TABLE 3. Calculations for estimated market size for milk protein in food aid.
Abbreviations: RUF, ready-to-use food; USAID, US Agency for International Development. 
Note: The 2017 Food for Peace funding values include only food aid, and exclude community development funds and economic support funds.
Sources:
i.  US Agency for International Development (USAID). Food for Peace Fiscal Year 2017 Year in Review. Washington, DC USA: USAID; 2017. https://www.usaid.gov/sites/default/files/documents/1866/
FY17_Annual_Report_FINAL_508_compliant.pdf.
ii.  US Agency for International Development (USAID). RUF: Ready-to-Use Nutritional Food for Use in International Food Assistance Programs. Washington, DC USA: USAID; 2015. https://www.usaid.gov/
sites/default/files/documents/1866/USAID_RUF_Specification.pdf.
iii.  Dairy for Global Nutrition website. Dairy price trends page. https://www.dairyglobalnutrition.org/price-and-supply-trends/dairy-price-trends. Accessed September 30, 2019.
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Of the global food aid market, it is unknown exactly 
how much of this is protein, or more specifically milk 
protein. Egg protein or egg powder was not identified 
as an ingredient in any food aid products. Stakeholders 
who participated in interviews for this project said that 
at present, milk is incorporated into only a few food aid 
products. Ready-to-use supplementary food, ready-to-use 
therapeutic food, Nutriset’s Plumpy’Nut®,48 and Super 
Cereal Plus are specialized food products known to contain 
milk protein and that are often provided through food aid 
channels. Approximately 10% to 15% of these products 
is milk protein by weight.49 Therefore, of the 3.125 billion 
kg of food aid donated annually by Food for Peace, it is 
estimated that a small fraction currently contains milk. This 
analysis estimates a range of 1% to 10%, which represents 
approximately 31 million to 312 million kg of milk protein 
(Table 3). Note that this is the volume of milk protein only, and 
not a complete milk product.
The estimated cost of the protein content of skim milk 
powder in 2017 was approximately $6 per kg of protein.50 
Applying this cost to the volume of milk proteins estimated 
above, the estimated market value for milk protein powder 
in the food aid market for Food for Peace is between $187 
million and $1.875 billion. It is important to note that the cost 
per kg of milk protein (assumed to be $6) is much higher than 
the average cost per kg across all types of food aid products 
($1.13, as stated above). 
Market size summary for milk and 
egg proteins in low- and lower-
middle income countries
The current market sizes for milk and egg proteins in the 
consumer and food aid markets in LMICs are summarized 
in Table 4. The current consumer market size for milk is the 
largest market, while the food aid milk market makes up a 
fraction of the consumer milk and consumer egg markets. 
Cultured proteins could be used as replacements for milk 
and egg proteins in existing spaces (e.g., consumer diets 
and food aid products that currently contain milk), or could 
be used to increase the size of the protein market as a 
whole (i.e., be added into diets or foods that do not already 
contain protein). One interview participant said that it would 
be possible to increase protein levels in food aid products 
generally by adding dried milk powder or milk protein 
isolates (including possibly cultured milk proteins) to existing 
food aid products that do not currently contain protein. 
Rising rates of alternative protein 
consumption in high-income 
countries
In high-income markets, the high consumption rates of 
animal-source milk and eggs, along with meat as a source of 
protein, are starting to be disrupted by alternative proteins, 
notably plant-based alternatives. In the United States, for 
example, sales of plant-based alternatives as a whole grew 
by more than 20% in 2018 to a total market of $3.3 billion, 
whereas sales of all foods grew by only 2% in comparison.51 
Plant-based milk sales grew 9% in 2018 and now represent 
15% of the total milk market, while sales of cow’s milk 
declined 6%. Similarly, sales of plant-based meats grew by 
24% in 2018, while animal meats grew by only 2%. Sales of 
plant-based eggs and plant-based mayonnaise grew 16%.51 
See Table 5 for more data. 
Similar trends have been seen in the United Kingdom, 
where 23% of households reported using plant-based milk 
at least once in the three months leading up to February 
2019, up from 19% in 2018. Overall, sales of plant-based 
milk have grown 30% in the United Kingdom since 2015.52 
The global plant-based milk industry was estimated to be 
approximately $16 billion in 2018, up from $7.4 billion in 2010 
(a 116% increase over eight years).53
This growth in plant-based protein sales may be attributed 
to a variety of factors. According to one expert, “The dairy 
alternatives market has seen rising levels of interest in 
recent years, spurred mainly by consumers increasingly 
looking for lactose-free, dairy-free, and plant-based/vegan 
options as healthy lifestyle choices, rather than regarding 
Consumer milk market 
(complete milk product, 2013)
Consumer egg market 
(complete egg product, 2013)
Food aid milk market  
(milk protein only, 2017)
Volume (kg) 210.7 billion 10.0 billion 31 million to 312 million 
Dollars (US) $291.6 billion $40.8 billion $187 million to $1.9 billion 
TABLE 4. Annual estimated market size for milk and eggs in low- and lower-middle income countries in 2017.
Note: The consumer milk and egg markets represent complete milk and egg products, while the food aid milk market represents the estimated market for milk proteins only. Generally, skim milk 
contains about 35% protein by weight.
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them as simply for those with allergies or intolerances.”53 
The number of lactose-intolerantf individuals may be up 
to two-thirds of the global population.52 Data from the 
United Kingdom have shown that 37% of individuals aged 
16 to 24 years—the leading consumers of plant-based 
milk—have reduced intake of cow’s milk for health reasons, 
while 36% agree that dairy farming negatively impacts the 
environment.54 Additionally, in the United Kingdom 40% of 
milk consumers reported they would be willing to pay more 
f. Lactose intolerance refers to the absence of the lactase enzyme to break down milk 
proteins.
than the current price of milk, indicating an ability to pay 
more for the product.54 It is important to note that most 
plant-based milks do not have the same protein content or 
amino acid profile as animal-source milks.52 While less of a 
consideration for high-income countries, in LMIC settings 
where animal-source protein is lacking, it is more important 
to secure sufficient high-quality “complete” proteins, which 
are largely found in animal-source foods (and not their 
plant-based alternatives).
Category Dollars (millions US) Year-over-year growth
Milk $1,600 9%
Meat $670 24%
Other plant-based dairy substitutes (total) $697 50%









Grand total $3,300 20%
TABLE 5. Market value and annual growth of plant-based alternatives in the United States, by category (2018).
Adapted from Plant Based Foods Association website. Consumer access: 2018 U.S. retail sales data for plant-based foods page. https://plantbasedfoods.org/consumer-access/nielsen-data-
release-2018/. Accessed September 30, 2019.
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• Five manufacturers of cultured proteins were included in this analysis, of 
which two are developing milk proteins, two are developing egg proteins, 
and one is developing a novel cultured protein.
• Most manufacturers formed their companies within the past five years, 
and the first products are expected to launch business-to-business in 
high-income markets in 2020.
• Some product attributes (e.g., room temperature storage and potential 
for improved shelf life) may make cultured proteins more suitable for use 
in LMICs than traditional animal-source milk and eggs.
• Most manufacturers are initially aiming to price products at parity to 
existing milk and egg products but acknowledged that price reductions 
are possible once the products are being sold at scale. To scale 
operations globally, two cultured protein companies have partnered with 
large, multinational food companies.
Key messages
Cultured protein manufacturer 
landscape
Key manufacturers
The market for cultured proteins is rapidly evolving, with new companies launching 
every year and most existing companies joining the market after 2015. As of 
February 2019, when this analysis began, approximately eight to ten major cultured 
protein manufacturers had been identified. Five of these manufacturers were 
included in this landscape: BioscienZ, Clara Foods, New Culture, Perfect Day, and 
Solar Foods. Each of these companies is working to develop a cultured dairy, 
egg, or other powdered protein product, though no cultured protein products 
are commercially available as of the time of writing. Information included in this 
section is from company websites, news articles, press releases, and stakeholder 
interviews. The information and tables below outline in further detail information 
about each selected cultured protein manufacturer and the key product attributes 
for their cultured protein products. 
BioscienZ
Netherlands-based BioscienZ was founded in 2011 as a consulting company 
and established its first laboratory in 2014 to transition into a solutions provider 
to conduct in-house contract research. It currently employees a staff of 
approximately ten people. In order to solve the global problem of how to feed a 
growing population, the company has both food projects and agricultural projects. 
On the food side, BioscienZ is looking to develop a fermentation-based egg white 
protein and a fermentation-derived plant-based meat product. These proteins 
are designed to be more environmentally responsible, sustainable, and efficient 
than animal-source proteins. The egg white protein is created by over-expressing 
a chicken ovalbumin gene in a fungus, which is fed sugar beets or grains to induce 
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fermentation. This product will be used in the company’s 
plant-based meat product as a binding agent, though may 
also be sold and used as a stand-alone liquid egg white 
product. BioscienZ received funding to develop its egg white 
protein in 2018 from the Dutch government’s Small Business 
Innovation Research Programme and in 2019 from the 
Municipality of Breda. It hopes to launch its first commercial 
product in 2024.55 See Table 6 for further details.
Clara Foods
Clara Foods was founded in 2015 out of IndieBio (a life 
sciences accelerator) and now has nearly 40 employees. 
The San Francisco, California, USA–based company has 
developed a technology to create a vegan replacement for 
egg white proteins, with the goal of producing nutritious 
proteins more sustainably than through livestock production. 
The proteins are created by a fermentation process that 
Protein 
type


























TABLE 6. Summary of BioscienZ’s cultured protein product attributes.
N/A: Information not available.
Sources: BioscienZ website. https://www.bioscienz.nl/. Accessed August 16, 2019. PATH interview with manufacturer.
involves cultivating yeast strains and feeding them a 
sugar substrate to produce tailor-made egg proteins. By 
focusing production on individual egg white proteins, 
Clara Foods can ensure higher purity and lower costs than 
would be feasible by creating a complex protein mix. This 
company is starting its product line with proteins found 
in chicken eggs. These manufactured proteins are better 
for the environment because less waste is produced in 
their creation. The additive products can be used as a 
performance supplement, preservative, baking product, 
food and beverage ingredient, or general egg replacement. 
Clara Foods received $15 million in Series A funding in 2016 
and Series B funding of $30 million in 2019. The company 
recently partnered with Ingredion, a global company focused 
on making ingredients such as sweeteners, starches, and 
biomaterials, to distribute and market their protein products, 
and plans to launch its first commercial product(s) in 2020.56 


































will match that 







TABLE 7. Summary of Clara Foods’ cultured protein product attributes.
N/A: Information not available.
*Price information was gathered based on available data. Prices are described differently and not necessarily comparable across companies.
Sources: Clara Foods website. https://www.clarafoods.com/. Accessed August 16, 2019. PATH interview with manufacturer.
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New Culture
New Culture was founded in 2018 with the goal of creating 
animal-free dairy cheese products, starting with mozzarella. 
The company is a recent member of San Francisco-based 
IndieBio’s four-month life science accelerator program 
and was granted $250,000 in seed funding to develop its 
proof of concept. Currently, New Culture has approximately 
four employees. Its animal-free, cholesterol-free, and 
lactose-free dairy cheese products are created using 
microbial fermentation to generate casein proteins, which 
give cheese its dairy characteristics. New Culture aims to 
improve upon traditional cheese manufacturing practices 
with respect to water usage, sustainability, animal 
welfare, land shortage, food shortage, and dairy allergies. 
While casein is the key ingredient in cheese, it will be 
supplemented with plant-based ingredients to create the 
mozzarella cheese product. The company recently secured 
a $3.5 million seed round and plans to launch this product 
commercially in 2023-2024.57 See Table 8 for further details.
Perfect Day
Perfect Day was founded by two co-founders who were 
passionate about creating vegan dairy products. After 
meeting through New Harvest, they created Perfect Day in 
2014, based in Emeryville, California, USA. The company 
was originally called Muufri, but the name was changed to 
Perfect Day in August 2016. Perfect Day, which has nearly 
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2023-2024 
TABLE 8. Summary of New Culture’s cultured protein product attributes.
*Price information was gathered based on available data. Prices are described differently and not necessarily comparable across companies.





















































TABLE 9. Summary of Perfect Day’s cultured protein product attributes.
*Price information was gathered based on available data. Prices are described differently and not necessarily comparable across companies.
Sources: Perfect Day website. https://www.perfectdayfoods.com/. Accessed August 16, 2019. PATH interview with manufacturer. 
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TABLE 10. Summary of Solar Foods’ cultured protein product attributes.
N/A: Information not available.
*Price information was gathered based on available data. Prices are described differently and not necessarily comparable across companies.
Sources: Solar Foods website. https://solarfoods.fi/. Accessed August 16, 2019. PATH interview with manufacturer.
70 employees, uses a fermentation process to create milk 
proteins. It introduces essential milk genes into microflora, 
which then convert plant sugar into whey and casein 
proteins. This protein can then be used to create vegan and 
lactose-free versions of cheese, yogurt, ice cream, and other 
products. The protein is also free of hormones, antibiotics, 
and cholesterol, and has the potential to have a longer shelf 
life than traditional milk. Perfect Day has received $61 million 
in funding through Series B. In the future, the company 
will likely sell its protein powder as an additive to other 
commercial food companies through a business-to-business 
(B2B) model. In 2018, it announced a key partnership with 
Archer Daniels Midland, one of the world’s largest agricultural 
processors and food ingredient providers, to help develop, 
scale, and commercialize production. Products are expected 
on the market in 2020.58 See Table 9 for further details.
Solar Foods
Solar Foods is a Finnish company with approximately 
six employees that was founded in late 2017 by scientific 
experts from the Technical Research Centre of Finland Ltd. 
and the Lappeenranta University of Technology. Its novel 
protein, Solein, was created using a concept from the US 
National Aeronautics and Space Administration space 
program. The company aims to produce “food out of thin 
air.” The fermentation process used to create Solein involves 
introducing carbon dioxide, hydrogen, and renewable 
energy into a unique, natural microorganism in water. The 
microorganism reproduces in a fermenter as it consumes 
carbon dioxide, hydrogen, and nitrogen. As the liquid is 
removed and dried, a powder is formed. The end product 
looks and tastes like wheat flour and includes 50% protein 
(covering all essential amino acids), along with fat, vitamins, 
and nutrients. This bioprocess could be used to create food 
ingredients, plant-based meat alternatives, or cultured 
meat. The company claims Solein is 100 times more climate 
friendly than any animal- or plant-based alternative. Solar 
Foods has received more than $2.2 million in two rounds of 
funding, and is hoping to launch its product in 2021.59 See 
Table 10 for further details.
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Product attributes
In order to compare cultured milk and egg proteins to 
animal-source milk and egg proteins, we captured 
information on several key product attributes, including 
those that may be relevant to the commercialization of 
cultured milk and egg proteins in LMIC markets. The earliest 
cultured protein products are expected on the market in 
early 2020 (in high-income countries); they are currently 
undergoing the final steps leading up to a product launch. 
Ahead of this, some companies may pre-launch products to 
create buzz around their brand. For example, in July of 2019, 
Perfect Day distributed a limited release (1,000 three-pack 
pints) vegan ice cream product made with cultured milk 
proteins that sold out in hours. However, most of the cultured 
protein companies interviewed, including Perfect Day, 
ultimately plan to produce ingredients they will sell to other 
companies via a B2B model. These buyers could then use 
them as ingredients in a variety of products. 
When compared to animal-based milk and eggs, cultured milk 
and egg proteins could have several advantages in LMICs. 
While more data are needed, some manufacturers mentioned 
the potential for the proteins to have a longer shelf life than 
proteins produced through traditional farming, given they are 
made in a more sterile environment with fewer contaminants. 
In addition, access to refrigeration and electricity is limited 
in LMICs, and at least one manufacturer of a cultured milk 
protein product claimed the product can be stored at room 
temperature (20°C). While the exact prices of these products 
are still unknown, most manufacturers aim to have their 
products priced at parity to animal-source proteins. Once 
the products are produced at scale, price reductions are 
possible. Given the price-sensitive nature of vulnerable 
populations in LMICs, reductions in price of cultured proteins 
over animal-source proteins will be critical for the successful 
market penetration of cultured proteins. However, when 
comparing the total cost of animal-source proteins versus 
cultured proteins, it is also important to consider other 
relevant costs such as those of delivery and refrigeration. 
Prioritized geographic and end 
user markets
Three interviewed companies plan to initially prioritize 
product launches in the United States, and two companies 
will likely first target product launches in Europe and 
Asia. These initial geographic markets were chosen by 
manufacturers for a variety of reasons. According to 
some, the United States is often an early adopter of new 
food and has established regulatory requirements (see the 
accompanying Policy and Regulatory Environment paper for 
more details). It has seen tremendous growth in the markets 
for other alternative protein products (e.g., plant-based 
meat and milk),60 has a relatively large market size (due to its 
large population), and is a high-income country with wealthy 
consumers. Multiple companies indicated that the European 
regulatory process will likely be lengthy and tedious, thus it 
may not be an ideal first market to enter. However, as noted 
previously, European consumers may be willing to pay more 
for high-quality proteins. 
Most of the companies included in this market landscape 
plan to begin selling B2B, primarily looking to sell their 
protein as an ingredient to major food companies. However, 
they have also done research to determine the consumer 
end users they would like to target. Initially, most companies 
plan to target consumers who are willing and able to pay a 
price premium for a high-quality protein product, produced 
without harming animals and with a better environmental 
footprint. Three cultured protein companies specifically 
mentioned targeting vegan markets (products will be 
labeled as vegan), as vegans may be attracted to innovative, 
animal-free versions of existing proteins. However, these 
companies also mentioned that vegans will likely not 
be the sole target consumer segment. Environmentally 
conscious consumers and consumers focused on proteins 
for improving health and athleticism were also mentioned 
as possible key consumer segments. New Culture, the 
only company making a complete product, plans to sell a 
business-to-consumer (B2C) retail product as their market 
entry strategy.61 While two companies stated they have 
considered the use of their products in LMICs or emergency 
relief settings, these would likely be lower-priority markets, 
targeted after they have achieved a larger scale and costs 
have decreased. Nevertheless, whey protein isolate is 
already part of USAID’s procurement list for food aid, and 
with new research on the role of animal-source proteins in 
human growth and development in LMIC settings,13,14 the food 
aid market for these products may grow in the future.
As a comparison, in addition to companies producing 
cultured milk and egg proteins, a variety of other alternative 
protein companies and products were reviewed to 
understand how producers are prioritizing geographic 
markets and market segments. These five additional 
companies were making products such as cell-based meat/
poultry (Memphis Meats, JUST, Higher Steaks), cell-based 
crustaceans (Shiok Meats), plant-based eggs (JUST), and 
plant-based meat alternatives (Impossible Foods). These 
companies are based in the United States (California: 
Memphis Meats, JUST, and Impossible Foods), the United 
Kingdom (Higher Steaks), and Singapore (Shiok Meats).
Similar to the cultured protein companies, most other 
alternative protein companies interviewed plan to launch 
products first (or have already launched) in the United 
States and higher-income regions of Asia. Europe was not 
mentioned. Asia is an appealing market to manufacturers 
for a variety of reasons. According to manufacturers, Asia 
is a large and fast-growing market (in terms of population), 
has a declining supply of animal-source foods,62 has affluent 
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populations that are willing to pay more, and includes 
regions that have high rates of importing meat and have 
shown interest in new food technologies (e.g., Singapore and 
Hong Kong). In addition, most high-income Asian countries 
have a well-defined food regulatory process and regulators 
who are open to supporting new food technologies. Unlike 
cultured protein companies, these other alternative 
protein companies employ a mix of B2B and business-to-
consumer approaches, with most planning to begin sales to 
high-end restaurants, along with either grocery stores, food 
companies for frozen meals, or other premium consumer 
markets. Many of these decisions were attributed to the 
fact that it is much easier to integrate innovative foods as 
ingredients or flavorings from a regulatory perspective, 
as opposed to selling directly to consumers (see the 
accompanying Policy and Regulatory Environment paper for 
more details).
These learnings from select cell-based meat and 
plant-based protein food manufacturers indicate there 
may be overlap between the markets for these two types of 
alternative proteins and the markets for cultured proteins. 
While cultured protein products are not currently available, 
there is a perceived market opportunity in high-resource 
settings. Given that these products may be competing with 
plant-based protein alternatives, the alternative protein 
space may become more crowded, creating competition 
and potentially market efficiencies. The LMIC market is likely 
much less contested and could potentially provide health 
benefits to malnourished populations as well as companies 
and their shareholders.
Partnerships
Two of the manufacturers included in the landscape have 
partnered with large, multinational food companies. Both 
companies have stressed that these partnerships are 
critical for scaling up operations. Larger-scale operations 
could create production efficiencies and drive down costs. In 
May of 2019, Clara Foods partnered with Ingredion, a global 
ingredient solutions provider. Ingredion makes sweeteners, 
starches, nutrition products, and other ingredients that are 
used for a variety of purposes and had net sales in 2018 
of $5.8 billion.63 The company currently has a presence in 
select LMICs, including offices in Kenya64 and Vietnam.65 
Clara Foods CEO Arturo Elizondo said, “We see extraordinary 
value in partnering with Ingredion to distribute our products 
globally and look forward to jointly transforming the status 
quo means of making animal protein at scale.”66
In November of 2018, Perfect Day announced their 
partnership with Archers Daniel Midland (ADM) to 
commercialize animal-free dairy products. ADM is one of the 
world’s largest agricultural processors and food ingredient 
providers. The company serves products to nearly 200 
countries globally, and has offices in select LMICs such as 
India, Indonesia, and Vietnam.67 In 2018, ADM’s net sales 
were $6.8 billion.68 Ryan Pandya, CEO of Perfect Day, said, 
“We are on a journey to bring sustainable, nutritious and 
delicious dairy to everyone. We are thrilled to partner with 
ADM, a global leader in fermentation, to accelerate our path 
to market. With this partnership, we will enable brands to 
make your favorite foods in a kinder, greener way.”69
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• Almost all stakeholders interviewed were either “very aware” or 
“somewhat aware” of cultured proteins prior to the interview, with 
positive perceptions of the proteins for use in LMICs.
• The most important expected key benefits of cultured proteins to 
stakeholders were that they have an equally high nutritional value, 
lower environmental footprint, and equivalent or lower cost than their 
respective animal-source proteins.
• Stakeholders questioned whether cost reductions were feasible, how 
potential GMO status may impact product labeling and market uptake, 
and whether consumers would readily adopt these new foods.
• Many stakeholders mentioned that milk and eggs have additional 
beneficial compounds besides proteins and that more evidence is 
needed on whether cultured proteins will provide similar nutritional 
benefits as the whole product.
• More data should be generated to show the benefits of cultured proteins 
in terms of cost and environmental impact.
Key messages
Stakeholder perceptions of cultured 
proteins
As part of the interview process, non-manufacturer stakeholders were interviewed 
about their previous knowledge of cultured proteins and their reactions to the 
concept card (Appendix A).g The concept card focused on the use of cultured 
proteins in LMICs, and the majority of respondents have experience working in 
LMIC markets. Key findings from the results of these questions are detailed below.
g. While the concept card was focused specifically on cultured milk and egg proteins, Solar Foods represents a company 
making a cultured protein product from the same process (fermentation-based cellular agriculture) but that does not directly 
replicate a milk or egg protein.  
Awareness and perceptions of cultured milk 
and egg proteins in low- and lower-middle 
income countries
Among 14 stakeholders, 9 claimed to be “very aware” of cultured milk and egg 
proteins before the interview, 4 claimed to be “somewhat aware,” and 1 claimed to 
be “not at all aware.” Overall, on a scale of 1 to 5, with 1 being “extremely negative” 
and 5 being “extremely positive,” the average perception of cultured proteins for 
use in LMICs was a 4.0 (n = 14). Interestingly, the perception of cultured proteins 
slightly increased with awareness level. The average perception of those who were 
“very aware” of cultured proteins was 4.3, compared to 3.8 for those “somewhat 
aware,” and 3.0 for the individual who was “not at all aware.” The stakeholders 
in nonprofit organizations (research/advocacy/professional groups) and other 
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stakeholders (in academia, donors, government, and 
independent experts) were almost all “very aware” of 
cultured proteins, while four of five food aid suppliers/
procurement/distribution agencies were only “somewhat 
aware.” See Table 11 for a summary of results. 
Top-valued attributes
Eight expected key benefits of cultured proteins were listed 
on the concept card (Appendix A).h These benefits, relative 
to traditional animal-source milk and egg proteins, were 
derived from secondary research and reviewed by select 
manufacturers. Compared to animal-source proteins, 
cultured proteins are expected to: 
• Contain the same high nutritional value.
• Have a lower environmental footprint and fewer 
greenhouse gas emissions.
• Require less agricultural inputs (e.g., land, water, energy).
• Do not require any animal breeding or slaughter (is a 
vegan product).
• Contain no hormones, antibiotics, or foodborne pathogens.
• May have an extended shelf-life (may not require cold 
storage).
h. While these benefits are expected, and were vetted with select manufacturers, data will 
need to be generated to support each of these claims.
• Have the same taste, texture, and chemical structure.
• May be lower-cost and/or have fewer cost fluctuations.
Of these attributes, stakeholders were asked to rank their 
top three perceived benefits in order of importance. The 
highest-ranking attribute was nutritional value, closely 
followed by lower environmental footprint. For nutrition, 
select stakeholders pointed out that cultured proteins could 
potentially have improved nutrition over their animal-source 
equivalents; for example, if undesirable contents, such 
as cholesterol, could be eliminated. However, multiple 
stakeholders also specified that while these cultured 
proteins could replace their equivalent animal-source 
proteins, many complete animal products (e.g., milk and 
eggs) have other important nutritional components besides 
the protein themselves.
The third highest ranked benefit was cost; however, this was 
also the most controversial. Many stakeholders indicated 
that cost is a key potential benefit of cultured proteins, if 
they can indeed be made at a lower cost than equivalent 
animal-source proteins. However, others did not believe this 
was possible, citing high production costs. All other factors 
were somewhat evenly distributed, and overall less important 
to stakeholders (though each did receive at least one first- or 
second-place ranking). See Figure 3 for a map of relative 
importance to stakeholders of each expected key benefit.
In addition to the listed benefits, stakeholders were asked 
if they saw other potential benefits that could come from 
Very aware Somewhat aware Not at all aware Total
Number of responses 9 4 1 14
Average perception score 4.3 (range: 2–5) 3.8 (range: 3–5) 3.0 (range: 3) 4.0 (range: 2–5)
TABLE 11. Summary of stakeholder awareness and perceptions.
Note: These questions were not asked to companies manufacturing cultured proteins.
FIGURE 3. Relative importance of expected key benefits to stakeholders.
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cultured proteins. Select additional benefits listed by 
stakeholders included:
• Cultured proteins could be specifically designed to fill a 
key protein gap (with a specific amino acid profile) for a 
particular context.
• The nutritional status of a product could be maximized by 
increasing protein content relative to other content (e.g., fat).
• If in-country production were feasible, local food security 
might improve.
• Products made with cultured proteins could be 
specifically regulated in terms of fat, sodium, 
carbohydrates, salt, and other relevant components of 
their nutrient profiles.
• Cultured proteins may not have the same allergens as 
animal-source proteins (e.g., lactose in milk), which may 
allow more people to benefit from them.
• Proteins may be easier to ship if a concentrated protein 
powder is produced (compared to eggs or liquid milk).
Potential challenges to 
commercialization and market 
uptake in low- and lower-middle 
income countries
Although cultured proteins were generally perceived 
positively by participating stakeholders, there were several 
mentions of potential challenges to commercialization 
and market uptake. The leading concern for stakeholders 
was cost, with low cost deemed as a key success factor 
for market uptake in LMIC settings. Many stakeholders 
mentioned these products will need to be priced on par 
with, or less than, traditional animal-source proteins to be 
adopted in LMIC markets. Stakeholders and manufacturers 
mentioned that a substantial up-front investment will be 
needed to build fermentation/product plants in order to 
scale production, improve production efficiencies, and 
drive down costs. Additionally, there are substantial 
costs associated with other parts of the process, such 
as purification (most cultured proteins will be sold in a 
purified form). Technological advances, such as less costly 
growth media or improved strains of microflora, could also 
potentially contribute to reduced prices. Two companies 
have partnered with large, multinational companies to help 
scaling efforts. 
Stakeholders also frequently mentioned potential challenges 
with regulation, labeling, and evidence. In some places, such 
as Europe (select countries), Ethiopia, and India, the fact that 
a GM product is used in the production of cultured proteins 
may pose a problem (see the accompanying Policy and 
Regulatory Environment paper for more details). Labeling 
was also frequently cited as a concern, and whether these 
products could be labeled as “GMO free,” “organic,” or other 
labels. This may be further complicated by lobbying from 
the dairy industry, which will not want these products to be 
labeled in the same way as animal-source products such 
as milk). In addition, some stakeholders noted the need for 
clinical studies to demonstrate effectiveness, especially for 
use in food aid products. 
Uncertainty around consumer acceptance was mentioned 
by stakeholders as a potential challenge. Stakeholders 
reported that consumers are often hesitant to accept 
new foods or food technologies, having concerns about 
their safety, inclusion of GMOs, or eating products that 
are not “natural.” While these products do not contain GM 
ingredients, they are made with a GM organism. Consumer 
acceptance of GM products is mixed globally. Additionally, 
it is unclear if consumers will like the taste and texture of 
the products. Furthermore, consumption of milk and eggs 
is low in many LMICs, thus consumers may be less likely to 
adopt cultured egg proteins if they are not already familiar 
with consuming animal-source eggs. Lastly, there was some 
concern regarding how cultured proteins may potentially 
negatively impact the livelihoods of farmers in LMICs (e.g., 
loss of jobs or cows as a financial asset).
Evidence desired to support 
adoption 
Some stakeholders said that additional evidence may be 
needed to support use in LMICs. One piece of evidence 
mentioned was data to prove these cultured proteins 
are equivalent to animal-source proteins. In addition, 
evidence supporting their digestibility, and how they differ 
from complete milk products, would be beneficial. Some 
stakeholders desired information on how the cost of cultured 
proteins compares to the cost of animal-source proteins, in 
addition to how the environmental footprint of generating 
cultured proteins is less than that of producing animal-source 
proteins. Consumer data may be needed to prove consumer 
acceptance and show that cultured proteins have an 
acceptable sensory profile. Finally, multiple stakeholders 
mentioned they trust guidance from select “well-regarded 
organizations” that work in the food industry, so generating 
buy-in from groups like the Good Food Institute, World Food 
Programme, United Nations Children’s Fund, US Food and 
Drug Administration, World Health Organization, FAO, and US 
Department of Agriculture may help to accelerate acceptance 
and adoption of these proteins.
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Conclusion
The cultured protein market in the United States and Europe is at a pivotal phase, 
with products expected to launch in early 2020. The rise of the plant-based milk 
market in high-resource markets, and the concurrent decline of animal-source 
milk, has demonstrated that consumers in high-resource markets are demanding 
alternative protein products and are often willing to pay a price premium for them. 
Cultured proteins have potential to tap into this consumer interest and further 
grow the alternative protein market. To match the growing demand, cultured 
protein manufacturers may initially target vegans, athletes, and environmentally 
conscious consumers in high-income countries. However, their products have 
several attributes that make them interesting for potential use in LMICs, in which 
select manufacturers have expressed interest as long-term market opportunities. 
For example, some cultured protein products may not need refrigeration and 
may have a longer shelf life than animal-source products. As electricity and 
refrigeration are often very limited in LMICs, a heat-stable protein powder may be a 
good fit in these settings.
While cultured protein manufacturers are aiming to have a similarly priced product 
to animal-source products, potential reductions in price may be possible with 
manufacturing efficiencies. Two cultured protein manufacturers have partnered 
with large, multinational corporations that can help create more efficient 
manufacturing processes and distribute their products on a larger scale. Because 
the fermentation-based manufacturing process is similar to producing beer, it 
may be possible to manufacture these products in LMICs to reduce distribution 
costs and decrease reliance on food imports. Lastly, stakeholders participating 
in this exercise (the majority of which have worked in LMIC settings) had positive 
perceptions of cultured proteins and thought there would be potential value for 
these products in LMIC markets. Many would like to see prices reduced and clinical 
evidence demonstrating the comparability to farm-raised animal proteins and 
the potential health benefits to vulnerable populations. In addition, stakeholders 
mentioned that close attention needs to be paid to possible disruptions in the 
livelihoods of LMIC farmers and mitigation strategies need to be developed to 
address this and other consumer concerns.
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Limitations 
There are several limitations with this analysis:
• Cultured protein products are not yet on the market. Therefore, their market 
potential is based on stakeholder perceptions and analysis of other alternative 
protein products that have already launched (plant-based replacements for 
animal-source proteins). 
• The cultured protein space is evolving rapidly, and the manufacturing landscape 
will shift in the future. Most cultured protein companies were founded less than 
five years ago.
• Final prices of cultured protein products are unknown. Manufacturers have 
indicated a desire to sell products at the same price as, or potentially a lower 
price than, animal-source proteins. They have also indicated that prices will 
likely decline once production of the products reaches scale.
• While stakeholder perceptions of cultured proteins were very positive, the 
sample size for this project was small; only 25 stakeholders participated in the 
interviews. Consumer perceptions in LMIC markets were not collected. 
• This paper does not directly assess the supply chain or distribution for cultured 
proteins, or the direct potential for these proteins to be produced in LMICs. We 
were unable to interview large, multinational food companies that work in the 
protein space for this analysis.
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Recommendations
Recommendations for future work to augment this analysis and generate further 
findings include:
• Develop a target product profile for a cultured protein product that could 
help ensure that product development efforts are aligned with the needs of 
consumers in LMICs.
• Conduct consumer acceptance studies to gain further insights into potential 
demand in LMICs, especially given the near-term time to launch of cultured 
proteins.
• Conduct costing analyses to understand the potential for cost reductions once 
cultured proteins are manufactured at scale and to understand other potential 
cost savings that cultured proteins may offer, such as delivery or refrigeration.
• Gather additional evidence on the impact of cultured proteins on health in 
vulnerable populations.
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Appendix 
Background
Undernutrition of children and mothers is the leading underlying 
cause of child morbidity and mortality worldwide,1 and is a 
significant health problem in low- and lower-middle income 
countries (LMICs). Low-quality diets that are lacking in essential 
proteins, sufficient energy, and essential vitamins and minerals 
are a key contributor to undernutrition.2 Studies have shown that 
increasing consumption of animal-source proteins can combat 
child malnutrition,3,4 while other studies have shown the negative 
agricultural and environmental impacts of raising livestock 
(including high land/water use requirements and greenhouse 
gas emissions).5 The commercialization of cultured proteins 
Production 
process
To produce cultured milk or egg proteins, the gene encoding the animal protein is introduced into the DNA 
of a starter culture of microflora (e.g., yeast or fungi). This culture is fed sugar and grown in controlled 
fermentation tanks, where it expresses the desired protein. This end protein is then separated from the 
host cells and purified into a powder (see Figure A). This fermentation process is similar to that of brewing 
beer or creating probiotics, and the proteins could potentially be manufactured in LMICs.
End product A purified protein powder that is identical in structural, organoleptic, and nutritional properties to the 
same protein derived from an animal source. This purified protein can be used as a stand-alone protein 
powder product or as an ingredient in other products, including animal-source food (e.g., milk or egg) 
substitutes. The final product is GMO free.
Development 
stage
Research and development 
Time to market Expected to launch in 2020 (at the earliest) for small scale/limited markets, with large scale/global 
production possible beginning in 2025.6
Target cost Final product cost will depend on the form of the end-product, and will differ between additive (e.g., 
purified milk protein powder) or complete (e.g., alternative milk that is ready for consumption) products. 
Cost will also depend on scale, and will likely decrease as sales and production capacity increase. 





• Contains the same, high nutritional value.
• Have a lower environmental footprint and fewer greenhouse gas emissions.
• Require less agricultural inputs (e.g., land, water, energy).
• Do not require any animal breeding or slaughter (is a vegan product).
• Contain no hormones, antibiotics, or food-borne pathogens.
• May have an extended shelf-life (may not require cold storage).
• Have the same taste, texture, and chemical structure.
• May be lower-cost and/or have fewer cost fluctuations.
TABLE A. Characteristics of cultured milk and egg proteins 
(also referred to as synthetic proteins, flora-based proteins, or 
fermentation-derived proteins) has the potential to increase access 
to high-quality and affordable proteins, which could sustainably 
support global nutrition while reducing the environmental and 
agricultural pressures of producing animal-source proteins. 
Cultured proteins, which are identical to their equivalent 
animal-source proteins, are made through cell cultures in a laboratory 
setting (Figure A). While this process can create many types of 
animal-source proteins, this concept card focuses specifically on 
“cultured” milk and egg proteins. Several emerging biotechnology 
companies are creating cultured milk and egg proteins for use in food 
products (Figure B), though none are yet commercially available.
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FIGURE A. Diagram of the production process for cultured milk and egg proteins.7
FIGURE B. Select cultured milk and egg protein manufacturers.
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